- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
CMS Replaces Departed CIO, COO
The CMS has moved quickly to replace two recently departed senior executives. The experience levels of the announced replacements should allay concerns that the mini-exodus, which some saw as fallout from launch issues with HealthCare.gov, would hurt agency operations, former CMS insiders agreed.
The CMS has moved quickly to replace two recently departed senior executives. The experience levels of the announced replacements should allay concerns that the mini-exodus, which some saw as fallout from launch issues with HealthCare.gov, would hurt agency operations, former CMS insiders agreed.
In a span of just weeks, starting in mid-November and ending in late December, both the CMS' Chief Information Officer Tony Trenkle and Chief Operating Officer Michelle Snyder left the agency, taking with them decades of institutional knowledge. Their departure capped off a year that also saw the CMS' Chief Actuary Richard Foster leave the agency after 18 years of service in January 2013.
But on Tuesday, the CMS announced it had promoted Tim Love to COO and Dave Nelson to CIO. Love has been with the CMS for the past 22 years, and was most recently acting deputy COO. Nelson has been with the agency 10 years and was most recently acting CIO. In June, the CMS tapped Paul Spitalnic as a replacement for Foster. He has been at the agency since 2003.
Read the full story here: http://bit.ly/1asbanr
Source: Modern Healthcare
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More
A Focus on MAHA, Lasting Changes to Health Care Programs for Trump’s Second Term
March 13th 2025The second Trump administration is expected to bring changes to Medicaid, Medicare Advantage, and the health insurance exchanges, as well as highlight the Make America Healthy Again (MAHA) movement, speakers at the Value-Based Insurance Design Summit said.
Read More
